Hi NZ Trader,
all depends on the trial results which should flow in by end of year for HerVaxx and sometimes between 4th quarter 2020 and 2nd quarter 2021 for CF 33 and maybe PD1-Vaxx. Plus the " mysterial " B-Vaxx with a ph2 update at anytime.
So, if Her-Vaxx delivers as expected it will open the doors for IMU as B-cell tech will become the new cutting edge tech and the pharma world will assume that PD1 and whatever comes next will perform as well. Same applies to CF33, once proven to be the next OV generation - the pharma universe is the limit.
Therefore, we could hope for a " launch " by end of the year / early 2021.
Unless some drugs being bought out / IMU taken over before that.
All in my opinion of course.
GLTA
Ann: Appendix 4C - quarterly, page-24
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 97 | 7481668 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1703097 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |